Web Exclusive: Jim Irsay in His Own Words
"It’s a tough situation for Peyton. He’s not used to being in this situation. We rode the elevator together after the Tampa Bay game, and I told him he has to cover himself with optimism. He knows he can’t will his way through this. It’s not like having a broken leg, and if he were tough enough, he could play through it. It’s not that kind of injury. And the number of years he has left is unknown. He’s 35. You hope that he can play until 38, 39, 40."
Modern Family: The Miller Home
The only details left uncovered are the homeowners’ identities and the whereabouts of the house itself. The mystery location of the house did little to stem the tide of attention for it.
First Internet Bank Makes a Virtual Withdrawal
Although First IB holds a lease on the prime street-level location until 2014, building management is shopping the space around--and evidently not having much luck. When CC emailed agent Stephen Adams, he replied, "Are you interested in leasing the corner space?" No, the Circle Citizen is quite comfy in his 40 Monument Circle digs, thank you. But he'd be delighted to call a bar his neighbor.
The Outrageous Fortune of Tim Durham
A federal jury found Indy financier Tim Durham guilty on 12 counts of fraud on June 20, 2012, and on Nov. 30, a federal judge sentenced him to 50 years in prison for milking Ohio investors of $250 million. Here's our story and an album of photos taken before the ruling passed down on this Ponzi schemer.
The Sound of Money: The Palladium Rises Up in Carmel
When Brainard first raised the idea of building a performing-arts center, the intent was to fill an immediate need: to give homeless arts organizations such as the Carmel Symphony Orchestra a place to play. It was a nice thought—quaint, really, considering what the city has now.
Tony Stewart Is Wheeling and Dealing
He passed Dale Earnhardt Jr. in merchandise sales—a remarkable feat considering Earnhardt’s legacy and loyal spectators.
Side Effects
With thousands of medical success stories and billions in revenue, officials at Lilly are still celebrating the success of Zyprexa. But its troubled path reveals volumes about how difficult bringing even an approved medication to market can turn out to be.
When We Build It, Will They Come?
The Indianapolis Colts, a winning team on the field, would not be financially viable in the modern NFL if they had to spend another two decades in the Hoosier Dome.